Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
Vaxess Technologies has raised $9.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Vaxess Technologies's investors include National Science Foundation, Bill & Melinda Gates Foundation, RA Capital Management, Verizon, Ulu Ventures.
Vaxess Technologies is headquartered in Cambridge, United States.
Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
Vaxess Technologies is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vaxess Technologies — Funding & Investors." VCBacked, April 9, 2025, https://www.vcbacked.co/company/vaxess-technologies. Accessed July 19, 2026.
VCBacked. (2025). Vaxess Technologies — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/vaxess-technologies
{{cite web |title=Vaxess Technologies — Funding & Investors |url=https://www.vcbacked.co/company/vaxess-technologies |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated